Vaccine News and Research

Latest Vaccine News and Research

Tuberculosis drugs under development could have large impact on the disease

The latest drug regimens, vaccines and diagnostic tools under development to combat tuberculosis could have a potentially large impact on the disease once they become available, according to research findings published in the Aug. 3 early edition online of the Proceedings of the National Academy of Sciences.

4 Aug 2009

Mathematical modelling to tackle influenza

Researchers from The University of Texas at Austin will participate in a $3 million, five-year grant from the National Institutes of Health (NIH) to fight influenza and other diseases by creating models that simulate the complex interplay between human behavior and the spread of disease.

4 Aug 2009

Will emphasis on prevention bring health costs down?

If there is one thing that both parties can agree on in the health overhaul debate, it’s the need to build a health system that promotes prevention rather than just manages disease.

4 Aug 2009

Scientists discover original source of malignant malaria

Researchers have identified what they believe is the original source of malignant malaria: a parasite found in chimpanzees in equatorial Africa.

3 Aug 2009

New research helps explain why treated genital herpes sores boost risk of HIV infection

New research helps explain why infection with herpes simplex virus-2 (HSV-2), which causes genital herpes, increases the risk for HIV infection even after successful treatment heals the genital skin sores and breaks that often result from HSV-2.

3 Aug 2009

AFP examines debate over H1N1 spending, resource allocation

There is concern that as developed countries store away antivirals, face masks and vaccines to protect against the H1N1 (swine) flu virus, poor countries are being left empty handed. "Some critics say the spending is so imbalanced that it amounts to health apartheid, protecting rich countries against H1N1 but leaving poor nations to fend for themselves," the news service writes, adding, "Others argue gargantuan sums are being spent on a disease that is no more lethal than seasonal flu, which is grotesquely disproportionate when thousands die each day of less media-friendly diseases."

3 Aug 2009

Opportunities and risks posed by synthetic biology

The new research field of synthetic biology will, in the medium term, open up a great deal of potential for combining novel genetic methods with engineering principles. This will facilitate the development, not only of new vaccines and medicines, but also of fuels and new materials.

3 Aug 2009

Ethical ramifications of H1N1 vaccine priority groups

Pregnant women are among the groups that should receive H1N1 (swine) flu vaccinations this fall, according to the Advisory Committee on Immunization Practices panel whose recommendations are generally accepted by the Centers for Disease Control and Prevention.

31 Jul 2009

U.S. decision on use of adjuvants could reduce world supply of H1N1 vaccine, says Lancet editorial

"A U.S. plan to rely on swine flu vaccines without ingredients to stretch the supply [known as adjuvants] would reduce the number of available shots just when other countries need them most, the British journal Lancet said in an editorial," Bloomberg writes.

31 Jul 2009

Mortality rates higher in hepatitis C virus carriers

Hepatitis C virus (HCV) is a blood-borne disease that causes inflammation of the liver and to which there is currently no vaccine available. The World Health Organization (WHO) estimates that 3% of the world's population, approximately 170 million people, are infected with HCV and it is a leading cause of liver cirrhosis, end stage liver disease, hepatocellular carcinoma (HCC) and liver transplantation.

31 Jul 2009

Medicago announces positive results for H1N1 pandemic vaccine candidate

Medicago today announced that it has achieved additional positive results with its vaccine candidate for the Influenza A (H1N1) virus, also known as Swine flu. Results showed that a single dose of 5 micrograms induced a positive immune response against a new emerging strain of this virus in 100% of vaccinated animals.

31 Jul 2009

Virulence of pandemic H1N1 virus analyzed

Laboratory studies at Kansas State University and the work of a K-State researcher are making headway in the effort to control the pandemic H1N1 virus.

31 Jul 2009

Malaria: Artemisinin resistance continues developing in western Cambodia

Artemisinin, the "basis of the most effective" malaria treatment recommended by the WHO, took nearly twice as long to clear malaria parasites in patients in western Cambodia than it did in patients in northwestern Thailand, according to a New England Journal of Medicine study, which shows the "drugs are losing their power against the disease in Cambodia," Bloomberg reports (Bennett, 7/30).

30 Jul 2009

New guidelines issued for H1N1 vaccine campaign by Federal Advisory Committee

During a meeting in Atlanta on Wednesday, a "federal advisory committee issued sweeping guidelines … for a vaccination campaign against the pandemic swine flu strain, identifying more than half the U.S. population as targets for the first round of vaccinations," CNN reports (Hellerman, 7/29).

30 Jul 2009

HIV/AIDS research initiative launched in South Africa

South Africa's Science and Technology Minister Naledi Pandor on Tuesday announced a government-sponsored research initiative that "aims to combat HIV and AIDS through scientific and technological research, the development of new drugs, diagnostic tests and vaccines," SAPA/IOL reports (7/28).

30 Jul 2009

Immune responses to flu vaccine are diminished in lupus patients

Patients with the autoimmune disease systemic lupus erythematosus (SLE) have an increased risk of infection, due to both disturbances in their immune responses and treatment with immunosuppressive drugs.

30 Jul 2009

South Africa, Lesotho, Swaziland encouraged to be 'vigilant' in staying polio free

At the 3rd Inter-Country Certification Committee Meeting -- where policymakers and experts from South Africa, Lesotho and Swaziland, the WHO and UNICEF gathered to address issues surrounding polio -- the WHO’s Nicholas Eseko lauded all three countries for becoming and staying polio free, according to BuaNews.

29 Jul 2009

Latin America accounts for two-thirds of all confirmed H1N1 deaths

Health officials are growing increasingly concerned over the impact the H1N1 (swine) flu is having on populations living in Latin America, a region "which accounts for around two-thirds of the 816 confirmed deaths so far from the disease," the AFP/channelnewsasia.com reports. "The outlook is especially unsettling for the estimated 380 million people grappling with winter in South America, where the A(H1N1) virus is speedily propagating," the news service writes.

29 Jul 2009

Malaria vaccine in the pipeline

Australian scientists have developed the first genetically-engineered malaria vaccine and the vaccine will be trialled in humans early next year.

29 Jul 2009

Swine Flu - getting drugs to the market more rapidly

The pharmaceutical industry has been up in arms this year. Giants such as Pfizer, GSK and AstraZeneca are looking for deals in the downturn whilst competing against increasing generic competition as some of the best selling medicines are coming off patent. In addition to the sectors ever-changing landscape companies are under tremendous pressure from governments to combat the Swine flu pandemic that has gripped the world.

29 Jul 2009